The subtitle gives away the issue. They make biology easier to scale. The one and only one way to do that is to reduce complexity. They have some method that w

The subtitle gives away the issue. They make biology easier to scale. The one and only one way to do that is to reduce complexity. They have some method that works in a restricted case. That is the benefit and deficit of using the platform. From working on flow cytometry software for >3 years I can say that has to be the case.